Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Recruiting3
Completed2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

completed240%
recruiting360%

Recent Activity

3 active trials
Showing 5 of 5
recruitingnot_applicable

Adipocyte-Derived Extracellular Vesicles, Weight Loss, and Endothelial Function

NCT06776081
recruiting

BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment

NCT06913712
completed

Cardiac Function and Biomarkers in Patients With Obesity and Overweight

NCT07455630
recruiting

Weight Loss Management in Endometrial Cancer Survivors

NCT06877572
completedphase_2

Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity

NCT02496611

Clinical Trials (5)

Showing 5 of 5 trials
NCT06776081Not Applicable

Adipocyte-Derived Extracellular Vesicles, Weight Loss, and Endothelial Function

Recruiting
NCT06913712

BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment

Recruiting
NCT07455630

Cardiac Function and Biomarkers in Patients With Obesity and Overweight

Completed
NCT06877572

Weight Loss Management in Endometrial Cancer Survivors

Recruiting
NCT02496611Phase 2

Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5